Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Colorcon
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

AN-SULFUR COLLOID Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover An-sulfur Colloid, and when can generic versions of An-sulfur Colloid launch?

An-sulfur Colloid is a drug marketed by Pharmalucence and is included in one NDA.

The generic ingredient in AN-SULFUR COLLOID is technetium tc-99m sulfur colloid kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m sulfur colloid kit profile page.

Summary for AN-SULFUR COLLOID
Drug patent expirations by year for AN-SULFUR COLLOID
Recent Clinical Trials for AN-SULFUR COLLOID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Navidea BiopharmaceuticalsPhase 1
Mitaka USA, Inc.N/A
Case Comprehensive Cancer CenterN/A

See all AN-SULFUR COLLOID clinical trials

US Patents and Regulatory Information for AN-SULFUR COLLOID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmalucence AN-SULFUR COLLOID technetium tc-99m sulfur colloid kit SOLUTION;INJECTION, ORAL 017858-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Medtronic
AstraZeneca
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.